SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Bought by Howard Capital Management Group LLC

Howard Capital Management Group LLC boosted its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 254,166 shares of the exchange traded fund’s stock after buying an additional 6,052 shares during the period. SPDR S&P Biotech ETF accounts for about 1.6% of Howard Capital Management Group LLC’s portfolio, making the stock its 28th largest holding. Howard Capital Management Group LLC owned 0.33% of SPDR S&P Biotech ETF worth $22,890,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Bank of New York Mellon Corp raised its stake in SPDR S&P Biotech ETF by 15.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 5,590 shares of the exchange traded fund’s stock valued at $518,000 after purchasing an additional 744 shares during the last quarter. Envestnet Asset Management Inc. raised its position in shares of SPDR S&P Biotech ETF by 12.5% in the second quarter. Envestnet Asset Management Inc. now owns 186,400 shares of the exchange traded fund’s stock valued at $17,281,000 after buying an additional 20,685 shares during the last quarter. Mercer Global Advisors Inc. ADV raised its position in shares of SPDR S&P Biotech ETF by 40.6% in the second quarter. Mercer Global Advisors Inc. ADV now owns 11,128 shares of the exchange traded fund’s stock valued at $1,032,000 after buying an additional 3,214 shares during the last quarter. AE Wealth Management LLC lifted its stake in shares of SPDR S&P Biotech ETF by 13.3% in the second quarter. AE Wealth Management LLC now owns 11,184 shares of the exchange traded fund’s stock worth $1,037,000 after buying an additional 1,314 shares in the last quarter. Finally, Bank of Montreal Can boosted its position in SPDR S&P Biotech ETF by 8.3% during the second quarter. Bank of Montreal Can now owns 231,432 shares of the exchange traded fund’s stock worth $21,556,000 after acquiring an additional 17,749 shares during the last quarter.

SPDR S&P Biotech ETF Trading Up 2.9 %

XBI stock opened at $90.51 on Wednesday. The firm has a 50-day moving average of $93.58 and a two-hundred day moving average of $96.95. SPDR S&P Biotech ETF has a 12 month low of $81.14 and a 12 month high of $105.47. The company has a market cap of $6.90 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.